Table 4 The association between CRP and clinicopathological features in patients with ovarian cancer
Variables | No. of studies | No. of patients | Effects model | OR (95%CI) | p | Heterogeneity | |
|---|---|---|---|---|---|---|---|
I2 (%) | Ph | ||||||
Age (years) (≥ 51 vs < 50) | 3 | 699 | Fixed | 1.11 (0.83–1.49) | 0.466 | 6.3 | 0.344 |
FIGO stage (III–IV vs I–II) | 3 | 699 | Fixed | 2.28 (1.67–3.13) | < 0.001 | 0 | 0.796 |
Residual tumor size (cm) (≥ 1 vs < 1) | 3 | 699 | Fixed | 3.62 (2.54–5.18) | < 0.001 | 48.9 | 0.141 |
Histologic grade (3 vs 1–2) | 2 | 602 | Fixed | 1.42 (1.02–1.99) | 0.040 | 0 | 0.591 |
Preoperative CA125 level (U/mL) (≥ 35 vs < 35) | 2 | 589 | Random | 6.25 (0.78–50.41) | 0.085 | 67.4 | 0.080 |
Volume of ascites (mL) (≥ 500 vs < 500) | 2 | 217 | Fixed | 8.16(3.52–18.92) | < 0.001 | 0 | 0.624 |